FDA Reviews Mustard, Celery, and Buckwheat for Inclusion as Major Food Allergens

The FDA's ingredient labeling rules are the invisible architecture of American grocery shopping, dictating exactly what must be declared on the back of every packaged food. For decades, the agency has mandated strict callouts for a core group of major food allergens, a list that currently stands at nine. Now, the FDA has initiated a formal review to determine whether mustard, celery, and buckwheat should join this mandatory disclosure roster. If approved, the move would fundamentally alter how food manufacturers and recipe developers declare ingredients, closing a long-standing loophole that allows potent allergens to hide behind generic terms.[1]

The mechanism governing these rules is the Food Allergen Labeling and Consumer Protection Act (FALCPA) of 2004. Under FALCPA, if an ingredient contains protein derived from one of the major allergens, its presence must be explicitly stated in plain language, either in the ingredient list or a separate 'Contains' statement. However, ingredients outside this list can legally be grouped under umbrella terms like 'spices,' 'natural flavors,' or 'broth.' For consumers with rare or emerging allergies, this regulatory blind spot turns everyday grocery shopping into a high-stakes guessing game.[1][4]

The push to review mustard, celery, and buckwheat is driven by a growing body of epidemiological evidence showing rising sensitization rates in North America. Medical researchers have noted that while these three ingredients are not currently recognized as major allergens in the United States, they are responsible for an increasing number of severe, anaphylactic reactions in emergency rooms. The FDA's review process will evaluate clinical data to determine if the prevalence and severity of these allergies meet the statutory threshold for mandatory labeling.[1][2]

Mustard is perhaps the most pervasive of the three candidates under review. It is a ubiquitous emulsifier and flavoring agent used in mayonnaise, salad dressings, marinades, and complex spice blends. Because mustard seed proteins are highly heat-stable and resistant to digestion, they frequently trigger systemic reactions even in trace amounts. Under current U.S. regulations, a manufacturer can list 'spices' on a bottle of barbecue sauce without disclosing that mustard powder is a primary component, leaving allergic consumers vulnerable to accidental exposure.[2][4]

Celery allergy presents a different clinical profile, often linked to pollen-food allergy syndrome, where the immune system cross-reacts with proteins found in birch or mugwort pollen. While some individuals experience mild oral symptoms, a subset of the population suffers from severe, systemic reactions to celery root (celeriac) and celery seed. In the commercial food supply, celery powder and celery salt are heavily utilized as natural curing agents in processed meats and as foundational flavor bases in canned soups and vegetable broths, often masked under the term 'natural flavorings.'[2]

Buckwheat, despite its name, is not related to wheat; it is a pseudocereal seed related to rhubarb and sorrel. Its consumption has surged in the United States over the last decade, driven largely by the booming market for gluten-free products and plant-based protein alternatives. As exposure has increased, so has the incidence of buckwheat anaphylaxis. The protein structure of buckwheat is highly allergenic for sensitized individuals, and cross-contamination in facilities that process multiple gluten-free grains has become a significant concern for allergists.[2][4]

The FDA's review also highlights a stark divergence between U.S. food safety regulations and international standards. The European Union currently recognizes 14 major food allergens, explicitly mandating the labeling of both mustard and celery across its member states. Similarly, Health Canada includes mustard on its list of priority food allergens. This regulatory asymmetry creates friction in the global food supply chain and leaves American consumers with fewer protections than their international counterparts when navigating packaged foods.[3][4]

Adding new allergens to the U.S. list is a notoriously slow and complex process. The FDA requires robust, peer-reviewed data demonstrating that an allergen causes a significant proportion of severe, life-threatening reactions in the U.S. population. The agency must weigh this clinical evidence against the economic impact on the food industry, which faces substantial costs associated with redesigning labels, auditing supply chains, and implementing new sanitation protocols to prevent cross-contact on shared manufacturing lines.[1][4]

The most recent addition to the U.S. allergen list provides a roadmap for how this process might unfold. Sesame was designated as the ninth major allergen following the passage of the FASTER Act in 2021, with enforcement beginning in January 2023. However, the sesame mandate required an act of Congress, raising questions about whether the FDA possesses the administrative authority to unilaterally add mustard, celery, and buckwheat through rulemaking, or if legislative intervention will be necessary once again.[1]

If the mandate moves forward, food manufacturers will face significant operational hurdles. Segregating ingredients like celery powder and mustard seed—which are deeply embedded in thousands of proprietary flavor formulas—requires meticulous supply chain tracing. Flavor houses, which traditionally guard their 'natural flavor' blends as trade secrets, would be forced to disclose the presence of these specific allergens to their downstream manufacturing partners, fundamentally altering industry transparency practices.[4]

Patient advocacy groups argue that the cost of compliance pales in comparison to the public health benefits. They emphasize that the current reliance on voluntary disclosure is inadequate, as it places the burden of safety entirely on the consumer. Advocates are urging the FDA to adopt a more dynamic, science-based framework for updating the allergen list, rather than relying on the decades-long intervals that have characterized past regulatory updates.[4]

However, the rollout of the sesame labeling rule also serves as a cautionary tale. Following the 2023 mandate, some commercial bakeries resorted to 'defensive labeling'—intentionally adding trace amounts of sesame flour to previously safe products and declaring it on the label. This practice was adopted because it was cheaper to add the allergen than to guarantee a completely sesame-free manufacturing line. Regulators and advocates are acutely aware that adding mustard, celery, and buckwheat could trigger a similar wave of defensive formulation, paradoxically reducing the number of safe options available to allergic consumers.[4]

For the broader culinary world, including recipe developers and home cooks, the FDA's review signals a broader cultural shift toward ingredient transparency. As awareness of emerging allergies grows, recipe publishers are increasingly moving away from vague instructions like 'add curry powder' or 'use vegetable broth,' instead specifying the exact components or offering safe substitutions. This grassroots shift in food media often outpaces federal regulation, reflecting a growing consumer demand for dietary clarity.[4]

The FDA's evaluation is expected to take at least 18 to 24 months, encompassing public comment periods, economic impact assessments, and scientific peer review. Even if the agency concludes that mustard, celery, and buckwheat meet the criteria for mandatory labeling, the subsequent rulemaking and compliance grace periods mean that updated labels would likely not appear on grocery store shelves until 2028 or 2029. Until then, consumers with these emerging allergies will have to continue navigating the opaque landscape of American food labeling.[1]